Laurus Labs Limited (NSE: LAURUSLABS) reported Revenue from Operations for Q3 FY23 of ₹1,544.82 Crore up from ₹1028.76 Crore year on year, a growth of 50%. Consolidated Net Profit of ₹277.85 Crore, up 31% from ₹154.97 Crore in the same quarter of the previous year. The Earnings per Share is ₹3.76 for this quarter.
Laurus Labs Limited Q3 FY23; Consolidated Revenue Jumps By 50%
Tags: pharmaceuticals
Related Post
- Syngene Q3 FY26 Earnings Results
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO)…
-
Grindwell Norton Q2 FY26 Earnings Results
Grindwell Norton Limited, engaged in manufacturing abrasives, ceramics & plastics and providing IT services, reported…
-
H.G. Infra Q2 FY26 Earnings Results
H.G. Infra Engineering Limited (HGIEL), an Indian road infrastructure company engaged in EPC services, maintenance…